Literature DB >> 27924427

Treatment of medication-related osteonecrosis of the jaws (MRONJ) with ultrasonic piezoelectric bone surgery. A case series of 20 treated sites.

Cornelio Blus1, Giulio Giannelli2, Serge Szmukler-Moncler3, Germano Orru3.   

Abstract

PURPOSE: There is no consensus on how to successfully treat medication-related osteonecrosis of the jaws (MRONJ). We report here on the application of piezoelectric bone surgery to treat MRONJ in combination with antibiotherapy and on its possible benefit. MATERIEL AND METHODS: A cohort of 18 consecutive patients has been treated for MRONJ; they involved 20 sites, 15 in the mandible, and five in the maxilla. Surgical removal of the necrotic areas and debridement was performed with a powerful piezoelectric surgery device (max 90 W) in combination with antibiotherapy.
RESULTS: All patients healed and obtained a complete soft tissue closure within 1 month. No recurrence of the symptoms was observed during the present follow-up (10-54 months).
CONCLUSION: We hypothesize that healing of all treated sites might have resulted from the synergic effect of bone ablation, biofilm alteration, and antibiotic administration. Biofilm alteration might have permitted a better access of antibiotics to the involved germs. These encouraging results warrant further studies on the use of ultrasonic surgery to treat MRONJ patients in order to confirm or refute the hypothesized effect.

Entities:  

Keywords:  Bacterial biofilm; Biphosphonate-related osteonecrosis of the jaw; MRONJ; Piezosurgery; Surgical management; Surgical treatment; Ultrasonic bone surgery

Mesh:

Substances:

Year:  2016        PMID: 27924427     DOI: 10.1007/s10006-016-0597-7

Source DB:  PubMed          Journal:  Oral Maxillofac Surg        ISSN: 1865-1550


  44 in total

1.  Early surgical laser-assisted management of bisphosphonate-related osteonecrosis of the jaws (BRONJ): a retrospective analysis of 101 treated sites with long-term follow-up.

Authors:  Paolo Vescovi; Maddalena Manfredi; Elisabetta Merigo; Rebecca Guidotti; Marco Meleti; Giuseppe Pedrazzi; Carlo Fornaini; Mauro Bonanini; Teore Ferri; Samir Nammour
Journal:  Photomed Laser Surg       Date:  2011-11-04       Impact factor: 2.796

2.  A prospective clinical trial for assessing the efficacy of a minimally invasive protocol in patients with bisphosphonate-associated osteonecrosis of the jaws.

Authors:  Filippo Moretti; Gian Andrea Pelliccioni; Lucio Montebugnoli; Claudio Marchetti
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2011-10-14

Review 3.  Piezosurgery in oral and maxillofacial surgery.

Authors:  G Pavlíková; R Foltán; M Horká; T Hanzelka; H Borunská; J Sedý
Journal:  Int J Oral Maxillofac Surg       Date:  2010-12-19       Impact factor: 2.789

Review 4.  Piezosurgery: basics and possibilities.

Authors:  Markus Schlee; Marius Steigmann; Emanuel Bratu; Arun K Garg
Journal:  Implant Dent       Date:  2006-12       Impact factor: 2.454

Review 5.  Management of Medication-Related Osteonecrosis of the Jaw.

Authors:  William Bradford Williams; Felice O'Ryan
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2015-11       Impact factor: 2.802

6.  Use of Ultrasonic Bone Surgery (Piezosurgery) to Surgically Treat Bisphosphonate-Related Osteonecrosis of the Jaws (BRONJ). A Case Series Report with at Least 1 Year of Follow-Up.

Authors:  Cornelio Blus; Serge Szmukler-Moncler; Giulio Giannelli; Gloria Denotti; Germano Orrù
Journal:  Open Dent J       Date:  2013-08-23

7.  American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma.

Authors:  James R Berenson; Bruce E Hillner; Robert A Kyle; Ken Anderson; Allan Lipton; Gary C Yee; J Sybil Biermann
Journal:  J Clin Oncol       Date:  2002-09-01       Impact factor: 44.544

8.  Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial.

Authors:  Lee S Rosen; David Gordon; N Simon Tchekmedyian; Ronald Yanagihara; Vera Hirsh; Maciej Krzakowski; Marek Pawlicki; Paul De Souza; Ming Zheng; Gladys Urbanowitz; Dirk Reitsma; John Seaman
Journal:  Cancer       Date:  2004-06-15       Impact factor: 6.860

9.  Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management.

Authors:  Lucio Montebugnoli; Laura Felicetti; Davide Bartolomeo Gissi; Angelo Pizzigallo; Gian Andrea Pelliccioni; Claudio Marchetti
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2007-05-07

10.  Cytokines and growth factors involved in the osseointegration of oral titanium implants positioned using piezoelectric bone surgery versus a drill technique: a pilot study in minipigs.

Authors:  Giulio Preti; Germana Martinasso; Bruno Peirone; Roberto Navone; Carlo Manzella; Giuliana Muzio; Crescenzo Russo; Rosa A Canuto; Gianmario Schierano
Journal:  J Periodontol       Date:  2007-04       Impact factor: 6.993

View more
  6 in total

1.  Oral Surgical Management of Bone and Soft Tissues in MRONJ Treatment: A Decisional Tree.

Authors:  Antonia Marcianò; Erasmo Rubino; Matteo Peditto; Rodolfo Mauceri; Giacomo Oteri
Journal:  Life (Basel)       Date:  2020-06-29

2.  Complementarity of Photo-Biomodulation, Surgical Treatment, and Antibiotherapy for Medication-Related Osteonecrosis of the Jaws (MRONJ).

Authors:  Diana Florina Nica; Mircea Riviș; Ciprian Ioan Roi; Carmen Darinca Todea; Virgil-Florin Duma; Cosmin Sinescu
Journal:  Medicina (Kaunas)       Date:  2021-02-05       Impact factor: 2.430

Review 3.  Various Therapeutic Methods for the Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ) and Their Limitations: A Narrative Review on New Molecular and Cellular Therapeutic Approaches.

Authors:  Sung-Woon On; Seoung-Won Cho; Soo-Hwan Byun; Byoung-Eun Yang
Journal:  Antioxidants (Basel)       Date:  2021-04-27

Review 4.  Oral Complications in Cancer Patients-Medication-Related Osteonecrosis of the Jaw (MRONJ).

Authors:  Cesar Augusto Migliorati
Journal:  Front Oral Health       Date:  2022-04-26

5.  Combined approach to treatment of advanced stages of medication-related osteonecrosis of the jaw patients.

Authors:  Onur Şahin; Ender Akan; Birkan Tatar; Ceren Ekmekcioğlu; Nuri Ünal; Onur Odabaşı
Journal:  Braz J Otorhinolaryngol       Date:  2021-05-06

6.  Patients' quality of life improves after surgical intervention of stage III medication-related osteonecrosis of the jaw.

Authors:  Stefan Moll; Steffen Mueller; Johannes K Meier; Torsten E Reichert; Tobias Ettl; Christoph Klingelhöffer
Journal:  Oral Maxillofac Surg       Date:  2020-11-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.